Description
Recombinant human monoclonal antibody against the Receptor Binding Domain of SARS-CoV-2 Spike protein (subunit 1). This product is produced in Nicotiana benthamiana plants for use in Western blot and ELISA applications.
Target
SARS-CoV-2 Spike protein (RBD of S1 subunit)
Target Alias Names
Anti-SARS-CoV-2 Receptor Binding Domain Antibody, Anti-RBD, Anti-RBD Antibody, CBT_A0005, Spike RBD, RBD Antibody, RBD Full Form, Receptor Binding Domain
Isotype/Mimetic
IgG1
Animal-Derived Biomaterials Used
None
Sequence Available
Yes
Original Discovery Method
Unknown
Antibody/Binder Origins
Unknown discovery source/method, In vitro recombinant expression